Physician profile
Jenna Powell
NPI 1629658026
$2,223.51
in general payments reported to CMS, 2019-2025
19 companies · $479 in 2025
The $479 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $83.88 · 2022: $697 · 2023: $450 · 2024: $514 · 2025: $479.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,352 · Education: $90.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,352.36 |
| Education | $90.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Mayne Pharma Commercial LLC | $450.13 | 2021-2025 | |
| Exeltis, USA INC. | $360.44 | 2021-2025 | Slynd |
| Abbvie INC. | $247.17 | 2022-2025 | |
| Astellas Pharma US INC | $205.67 | 2022-2024 | Veozah |
| Sage Therapeutics, LLC | $125.69 | 2022-2025 | Zurzuvae |
| Myovant Sciences INC. | $118.10 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $98.28 | 2022-2025 | |
| Agile Therapeutics, INC. | $94.52 | 2021-2024 | Twirla |
| Organon LLC | $84.18 | 2022-2025 | Jada System, Nexplanon |
| Aspira Women'S Health INC | $77.29 | 2022 | |
| Pfizer INC. | $72.13 | 2024-2025 | |
| Therapeuticsmd, INC. | $68.20 | 2021-2022 | |
| Evofem Biosciences, INC. | $55.98 | 2022 | |
| Avion Pharmaceuticals | $51.48 | 2022 | |
| Coopersurgical, INC. | $29.91 | 2023 | Paragard T 380a |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $27.28 | 2025 | The Cologuard Plus Collection Kit |
| Millicent US INC | $25.38 | 2025 | Intrarosa, Femlyv |
| Currax Pharmaceuticals LLC | $16.82 | 2022 | |
| Novo Nordisk INC | $14.86 | 2023 | Wegovy |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jenna Powell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.